if novartis knows anything about otat outcome, wouldn't we also know.
maybe its because we don't currenty have any evidence that it will benefit in over 65, which is the vast majority of all cause ards cases.
OTAT Meeting, page-32
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.44 |
Change
-0.005(0.35%) |
Mkt cap ! $1.609B | |||
| Open | High | Low | Value | Volume |
| $1.44 | $1.46 | $1.40 | $2.902M | 2.034M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 19 | 29997 | $1.44 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.44 | 7308 | 8 |
View Market Depth
| Last trade - 15.13pm 15/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |